Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.21
-8.81 %
$ 1.61 B
Market Cap
81.4
P/E
Price Target
Average
100.66%
Revenue Forecast
Estimate
22.47%
EBIT
Estimate
--40.26%
Net Income
Estimate
116.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dynavax Technologies Corporation
Wall Street analysts predict an average 1-year price target for DVAX of $24.5 , with forecasts ranging from a low of $20 to a high of $29 .
DVAX Lowest Price Target
Wall Street Target
20 USD
63.80%
DVAX Average Price Target
Wall Street Target
24.5 USD
100.66%
DVAX Highest Price Target
Wall Street Target
29 USD
137.51%
REVENUE FORECAST
Revenue Forecast Chart DVAX
EBIT FORECAST
EBIT Forecast Chart DVAX
NET INCOME FORECAST
Net Income Chart DVAX